Faraday Future Intelligent Electric Inc. saw its stock drop nearly 40% despite recent product showcases, indicating investor worries beyond its new offerings. Zevra Therapeutics' shares fell almost 24% after the European Medicines Agency issued a negative opinion on its drug arimoclomol. Leveraged and inverse ETFs linked to these and other stocks also experienced sharp declines, reflecting amplified market movements. These events highlight the impact of regulatory decisions and market structure on stock performance and investor sentiment.
Baker Hughes Company is set to report its Q2 2026 earnings with analysts forecasting EPS between $0.49 and $0.51 and revenue around $6.49 to $6.51 billion, both reflecting a year-over-year decline. Despite this, the company has a solid track record o...
Stocks of several companies jumped significantly today due to key corporate developments. STAK Inc. led with a 596% rise after announcing a U.S. subsidiary to develop power systems for AI data centers, highlighting investor interest in AI infrastruct...
NovaBridge Biosciences announced its annual general meeting (AGM) will be held on September 8, 2026, in Shanghai. The company is advancing clinical-stage biopharmaceutical treatments, including givastomig for gastric cancer and VIS-101 for retinal di...
Pelthos Therapeutics announced its 2026 Annual Meeting of Stockholders will be held virtually on September 29, 2026, at 9:00 a.m. Eastern Time. Stockholders of record as of August 4, 2026, are eligible to vote. The company will file the official noti...
Mdxhealth announced it received a Nasdaq notification for failing to meet the minimum market value of listed securities requirement of $35 million. The company has 180 days, until January 19, 2027, to regain compliance by exceeding this market value ...
